Main Article Content

Светлана Владимировна Шрамко
Наталья Михайловна Жилина
Мария Викторовна Чифранова
Людмила Владимировна Ренге
Сергей Александрович Долгих

Abstract

The etiology and pathogenesis of ovarian cancer have not been fully studied. The disease proceeds aggressively, is characterized by late diagnosis, high mortality rate and significant prevalence rate in economically developed countries. Novokuznetsk is a major industrial center of Kuzbass, and one of the most environmentally unfriendly regions in the Russian Federation, with a high cancer morbidity and mortality of the population, which is the reason for the analysis.

The purpose of the study. To study the dynamics of ovarian cancer rate in the residents of Novokuznetsk from 2008 to 2020 and to conduct a comparative analysis with the average incidence rates in Russia and a number of other countries.

Research methods. Statistical reports of the regional clinical oncological dispensary (Novokuznetsk branch) for 2008-2020 were used for the analysis. The licensed statistical package IBM SPSS Statistics-19 was used for the analysis. The following statistical methods were used: calculation of median values of indicators, upper and lower quartiles; Kendall tau rank correlation coefficient method (Ʈ), Mann–Whitney U test (U).

Results. During the study period, there was a tendency to decrease the absolute incidence of ovarian cancer along with a significant increase in five-year survival rate. High mortality was recorded in the 1st year of observation, along with predominantly late diagnosis of the disease (III and IV stages). The risk zone included women of postmenopausal age – 65-69 years.

Conclusion. High mortality rates of ovarian cancer patients in the 1st year of observation are due to late detection, which requires the legalization of screening programs with the inclusion of biochemical markers of tumors of various histotypes in the algorithm and coverage of women, except for unemployed, but at the same time under high cancer risk (65-69 years).

Keywords

ovarian cancer, oncopathology of female genital organs, frequency of ovarian cancer

Author Biographies

Светлана Владимировна Шрамко,
doctor of medical sciences, docent, professor of the department of obstetrics and gynecology
Наталья Михайловна Жилина,
doctor of technical sciences, docent, head of the department of medical cybernetics and informatics
Мария Викторовна Чифранова,
deputy head for medical affairs, Novokuznetsk branch of the Kuzbass
Людмила Владимировна Ренге,
doctor of medical sciences, docent, head of the department of obstetrics and gynecology
Сергей Александрович Долгих,
candidate of medical sciences, head of the organizational and methodological department

Article Details

Information about financing and conflict of interests

The study had no sponsorship.
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.

How to Cite

Шрамко, С. В., Жилина, Н. М., Чифранова, М. В., Ренге, Л. В., & Долгих, С. А. (2022). OVARIAN CANCER: INCIDENCE DYNAMICS IN NOVOKUZNETSK RESIDENTS FOR THE PERIOD 2008-2020. Mother and Baby in Kuzbass, 23(4), 29-35. https://doi.org/10.24412/2686-7338-2022-4-29-35

References

Semiglazov VV, Protasova AE, Kalikeev GK. Features of the clinical course and treatment of hereditary forms of breast cancer and ovarian cancer. Tumors of female reproductive system. 2020; 16(4): 54-65. Russian (Семиглазов В.В., Протасова А.Э., Каликеев Г.К Особенности клинического течения и лечения наследственных форм рака молочной железы и рака яичников //Опухоли женской репродуктивной системы. 2020. Т. 16, № 4. С. 54-65.) doi: 10.17650/1994-4098-2020-16-4-54-65

Payanidi YuG, Abramov PM, Gokadze NN, Esenova ME, Tikhonovskaya MN, Zhordania KI. The role of genetic and epigenetic disorders of the BRCA1 gene in ovarian cancer and breast cancer. Gynecologic Oncology. 2020; 1(33): 40-48. Russian (Паяниди Ю.Г., Абрамов П.М., Гокадзе Н.Н., Эсенова М.Э., Тихоновская М.Н., Жорданиа К.И. Роль генетических и эпигенетических нарушений функций гена BRCA1 при раке яичников и раке молочной железы //Онкогинекология. 2020. Т. 33, № 1. С. 40-48). doi: 10.52313/22278710_2020_1_40

Bazhenova LG. Diagnosis of ovarian cancer in the practice of an obstetrician-gynecologist. Novokuznetsk, 2017. 197 p. Russian (Баженова Л.Г. Диагностика рака яичников в практике акушера-гинеколога. Новокузнецк, 2017. 197 с.)

Piruzyan LA, Kabankin AS, Nikolaeva IS, Gulazizova KS, Sintsov AV, Sukhinina GP, et al. Study of the dependence of oncological morbidity in various ethnic populations on geographical latitude. Technologies of Living Systems. 2012; 9(1): 13-20. Russian (Пирузян Л.А., Кабанкин А.С., Николаева И.С., Гюльазизова К.С., Синцов А.В., Сухинина Г.П., и др. Исследование зависимости онкологической заболеваемости в различных этнических популяциях от географической широты //Технологии живых систем. 2012. Т. 9, № 1. С. 13-20)

Borisenkov MF, Anisimov VN. Cancer risks in women: possible connection with geographical latitude and some economic and social factors. Problems of oncology. 2011; 57(3): 343-354. Russian (Борисенков М.Ф., Анисимов В.Н. Риски развития рака у женщин: возможная связь с географической широтой и некоторыми экономическими и социальными факторами //Вопросы онкологии. 2011. Т. 57, № 3. С. 343-354)

Janowsky EC, Lester GE, Weinberg CR, Millikan RC, Schildkraut JM, Garrett PA, Hulka BS. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr. 1999; 2(3): 283-291. doi: 10.1017/s1368980099000385

Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, et al. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol. 2005; 23(36): 9312-9318. doi: 10.1200/JCO.2005.03.3266

Lefkowitz ES, Garland CF. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol. 1994; 23(6): 1133-1136. doi: 10.1093/ije/23.6.1133

GLOBOCAN Cancer Incidence and Mortality Worldwide in 2022. http://globocan.iarc.fr

Bazhenova LG, Viblaya IV, Skorytchenko NV. Dynamics of the incidence of ovarian cancer in different age groups of the female population of Novokuznetsk for the period 1992-2002. Russian Bulletin of obstetrician-gynecologist. 2004; 4(3): 55-60. Russian (Баженова Л.Г., Виблая И.В., Скорытченко Н.В. Динамика заболеваемости раком яичника в разных возрастных группах женского населения Новокузнецка за период 1992-2002 гг. //Российский вестник акушера-гинеколога. 2004. Т. 4, № 3. С. 55-60)

Shramko SV, Bazhenova LG, Chefranova MV. Proliferative benign and malignant diseases of the reproductive organs in the residents of Novokuznetsk: analysis of the dynamics of demographic indicators. Medicine in Kuzbass. 2016; 15(3): 56-62.) Russian (Шрамко С.В., Баженова Л.Г., Чифранова М.В. Пролиферативные доброкачественные и злокачественные заболевания репродуктивных органов у жительниц г. Новокузнецка: анализ динамики демографических показателей //Медицина в Кузбассе. 2016. Т. 15, № 3. С. 56-62)

Gorobtsova VV. Statistics, epidemiology, approaches to ovarian cancer therapy in the Rostov region. Chief physician of the South of Russia. 2018; 3(62): 39-41. Russian (Горобцова В.В. Статистика, эпидемиология, подходы к терапии рака яичников в Ростовской области //Главный врач Юга России. 2018. Т. 62, № 3. С. 39-41)

Nikoghosyan SO, Zagashtokov AZ, Levchenko NE, Tkhakokhov MM. Prognostic models in the diagnosis of ovarian cancer. Tumors of female reproductive system. 2018; 14(2): 82-89. Russian (Никогосян С.О., Загаштоков А.З., Левченко Н.Е., Тхакохов М.М. Прогностические модели в диагностике рака яичников //Опухоли женской репродуктивной системы. 2018. Т. 14, № 2. С. 82-89.) doi: 10.17650/1994-4098-2018-14-2-82-89

Baldwin LA, Huang B, Miller RW. Tucker T, Goodrich ST, Podzielinski I, et al. Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol. 2012; 120(3): 612-618. doi: 10.1097/AOG.0b013e318264f794

Malignant neoplasms in Russia in 2020 (morbidity and mortality) /ed. Kaprin AD, Starinsky VV, Shakhzadova AO. M., 2021. 252 p. Russian (Злокачественные новообразования в России в 2020 году (заболеваемость и смертность) /под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М., 2021. 252 с.)

Polevshchikov АВ, Nazarov PG. Immunity, aging and the works of VM Dilman. Advances in Gerontology. 2020; 33(5): 838-853. Russian (Полевщиков А.В., Назаров П.Г. Иммунитет, старение и работы В.М. Дильмана //Успехи геронтологии. 2020. Т. 33, № 5. С. 838-853.) doi: 10.34922/AE.2020.33.5.003

Gulyaeva LF, Vavilin VA, Lyakhovich VV. Xenobiotic biotransformation enzymes in chemical cancerogenesis. Ecology. A series of analytical reviews of world literature. 2000; 57: 1-85. Russian (Гуляева Л.Ф., Вавилин В.А., Ляхович В.В. Ферменты биотранформации ксенобиотиков в химическом канцерогенезе //Экология. Серия аналитических обзоров мировой литературы. 2000. № 57. С. 1-85)

Kukubasov EK, Satanova AR, Bolatbekova RO, Kaldybekov DB, Kurmanova AA, Bertleuov OO. Epidemiology of ovarian cancer in Kazakhstan (2013-2018). The Oncology and Radiology of Kazakhstan. 2020; 2(56): 9-11. Russian (Кукубасов Е.К., Сатанова А.Р., Болатбекова Р.О., Калдыбеков Д.Б., Курманова А.А., Бертлеуов О.О. Эпидемиология рака яичников в Казахстане (2013-2018 годы) //Онкология и радиология Казахстана. 2020. № 2(56). С. 9-11)

Abaidullina RR, Fedorov NM, Kovalchuk AA. Epidemiology of ovarian cancer in the Tyumen region in the period from 2009 to 2019. Academic Journal of West Siberia. 2021; 17(3-92): 18-19. Russian (Абайдулина Р.Р., Федоров Н.М., Ковальчук А.А. Эпидемиология рака яичников в Тюменской области в период с 2009 по 2019 гг. //Академический журнал Западной Сибири. 2021. Т. 17, № 3(92). С. 18-19)

Downloads

Download data is not yet available.

Most read articles by the same author(s)

1 2 > >>